Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,801 USD | +6,80% | -10,47% | +20,63% |
Vakgebied
Aantal werknemers: 66
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 14 | 100,0 % | 16 | 100,0 % | +11,66% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lucinda Quan
FOU | Founder | 51 | 05-02-18 |
Lawrence Blatt
CEO | Chief Executive Officer | 62 | 05-02-18 |
Lesley Calhoun
DFI | Director of Finance/CFO | 58 | 01-06-20 |
Matthew McClure
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-08-19 |
Julian Symons
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-05-18 |
Jordyn Tarazi
IRC | Investor Relations Contact | - | 13/02 |
Human Resources Officer | - | - | |
Corporate Officer/Principal | 58 | 01-08-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lawrence Blatt
CEO | Chief Executive Officer | 62 | 05-02-18 |
Director/Board Member | 63 | 01-08-18 | |
K. Hirth
BRD | Director/Board Member | 72 | 01-08-18 |
Jim Scopa
BRD | Director/Board Member | 65 | 27-04-21 |
Jack Nielsen
BRD | Director/Board Member | 60 | 01-08-18 |
Bridget Martell
BRD | Director/Board Member | 58 | 16-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 3 092 338 | 0 | 0 | 75,68 % |
Aandeel B | 1 | 72 576 183 | 57 263 778 ( 78,90 %) | 0 |
Bedrijfsgegevens
Aligos Therapeutics, Inc.
1 Corporate Drive 2nd floor
94080, South San Francisco
+800 466 6059
http://www.aligos.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,63% | 60,61 mln. | |
-0,02% | 42,11 mld. | |
+46,00% | 40,08 mld. | |
+5,04% | 40 mld. | |
-11,32% | 26,87 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. |
- Beurs
- Aandelen
- Koers ALGS
- Onderneming Aligos Therapeutics, Inc.